Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabio Angeli

Showing results (51-60 of 313) with videos related to

Pageof 32
Sort By:
European Journal of Internal Medicine|July 17, 2025
Baseline risk and outcome benefit from intensive blood pressure targeting. A systematic reviewPaolo Verdecchia, Fabio Angeli, Gianpaolo Reboldi
European Journal of Internal Medicine|October 18, 2023
Global burden of new-onset hypertension associated with severe acute respiratory syndrome coronavirus 2 infectionFabio Angeli, Martina Zappa, Paolo Verdecchia
Expert Opinion on Investigational Drugs|June 26, 2023
Long COVID [post-acute sequelae of coronavirus disease 2019]: experimental drugs for cardiopulmonary complicationsFabio Angeli, Paolo Verdecchia, Gianpaolo Reboldi
Journal of Human Hypertension|May 14, 2020
Management of hypertension in the very old: an intensive reduction of blood pressure should be achieved in most patientsFabio Angeli, Gianpaolo Reboldi, Paolo Verdecchia
The New England Journal of Medicine|October 24, 2019
Systolic and Diastolic Blood Pressure and Cardiovascular OutcomesPaolo Verdecchia, Fabio Angeli, Gianpaolo Reboldi
Giornale Italiano Di Cardiologia (2006)|November 30, 2021
[The STEP trial: how low should we go with blood pressure in hypertensive patients?]Paolo Verdecchia, Fabio Angeli, Gianpaolo Reboldi
Expert Opinion on Pharmacotherapy|October 12, 2021
Pharmacotherapy for hypertensive urgency and emergency in COVID-19 patientsFabio Angeli, Paolo Verdecchia, Gianpaolo Reboldi
Journal of Cardiovascular Development and Disease|March 24, 2022
Advances in the Treatment Strategies in Hypertension: Present and FuturePaolo Verdecchia, Claudio Cavallini, Fabio Angeli
European Journal of Internal Medicine|April 22, 2023
Is the competition between variants the end of severe acute respiratory syndrome coronavirus 2 pandemic? A journey from Wuhan to XBB.1.16Martina Zappa, Paolo Verdecchia, Fabio Angeli
European Journal of Internal Medicine|November 11, 2019
Hypertensive urgencies and emergencies: Misconceptions and pitfallsFabio Angeli, Gianpaolo Reboldi, Paolo Verdecchia
Pageof 32

Showing results (51-60 of 313) with videos related to

Sort By:
Pageof 32
European Journal of Internal Medicine|July 17, 2025
Baseline risk and outcome benefit from intensive blood pressure targeting. A systematic reviewPaolo Verdecchia, Fabio Angeli, Gianpaolo Reboldi
European Journal of Internal Medicine|October 18, 2023
Global burden of new-onset hypertension associated with severe acute respiratory syndrome coronavirus 2 infectionFabio Angeli, Martina Zappa, Paolo Verdecchia
Expert Opinion on Investigational Drugs|June 26, 2023
Long COVID [post-acute sequelae of coronavirus disease 2019]: experimental drugs for cardiopulmonary complicationsFabio Angeli, Paolo Verdecchia, Gianpaolo Reboldi
Journal of Human Hypertension|May 14, 2020
Management of hypertension in the very old: an intensive reduction of blood pressure should be achieved in most patientsFabio Angeli, Gianpaolo Reboldi, Paolo Verdecchia
The New England Journal of Medicine|October 24, 2019
Systolic and Diastolic Blood Pressure and Cardiovascular OutcomesPaolo Verdecchia, Fabio Angeli, Gianpaolo Reboldi
Giornale Italiano Di Cardiologia (2006)|November 30, 2021
[The STEP trial: how low should we go with blood pressure in hypertensive patients?]Paolo Verdecchia, Fabio Angeli, Gianpaolo Reboldi
Expert Opinion on Pharmacotherapy|October 12, 2021
Pharmacotherapy for hypertensive urgency and emergency in COVID-19 patientsFabio Angeli, Paolo Verdecchia, Gianpaolo Reboldi
Journal of Cardiovascular Development and Disease|March 24, 2022
Advances in the Treatment Strategies in Hypertension: Present and FuturePaolo Verdecchia, Claudio Cavallini, Fabio Angeli
European Journal of Internal Medicine|April 22, 2023
Is the competition between variants the end of severe acute respiratory syndrome coronavirus 2 pandemic? A journey from Wuhan to XBB.1.16Martina Zappa, Paolo Verdecchia, Fabio Angeli
European Journal of Internal Medicine|November 11, 2019
Hypertensive urgencies and emergencies: Misconceptions and pitfallsFabio Angeli, Gianpaolo Reboldi, Paolo Verdecchia
Pageof 32